Recombinant RAT dll4 Protein，His

DLL4 (Delta-like ligand 4) is a member of the Notch signaling pathway that plays a crucial role in various biological processes, particularly in vascular development, immune response, and tumor biology. Research has shown that DLL4 is involved in the regulation of endothelial cell function and angiogenesis, influencing how blood vessels form and mature. Its expression is often upregulated in various cancers, where it can promote tumor growth and metastasis by facilitating the formation of new blood vessels that supply nutrients to rapidly growing tumors. As a result, DLL4 has become a target for therapeutic strategies aiming to disrupt aberrant angiogenesis in cancer treatment. Recombinant DLL4 proteins have been generated for both experimental and therapeutic purposes, allowing researchers to study its role in cellular signaling, identify potential inhibitors, and explore its implications in combination therapies. Understanding the molecular mechanisms of DLL4 in these contexts could lead to the development of more effective treatments for cancer and other diseases involving dysfunctional angiogenesis. As such, DLL4 recombinant protein research represents a significant area of interest in molecular biology and therapeutic development, with the potential to enhance our understanding of tumor biology and lead to novel clinical interventions.